The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Use a concentration of 3 - 5 µg/ml. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Use a concentration of 1 - 3 µg/ml. Detects a band of approximately 75 kDa (predicted molecular weight: 59 kDa). An approximately 75 kDa band is observed in Human lysates of the cell line HeLa. The observed molecular weight corresponds to earlier findings with different antibodies from other commercial sources.
Use a concentration of 3 - 5 µg/ml.
功能May be involved in several stages of intracellular trafficking. Plays a role in targeting ligand-activated EGFR to the lysosomes for degradation after endocytosis from the cell surface and release from the Golgi. Component of the retromer complex, a complex required to retrieve lysosomal enzyme receptors (IGF2R and M6PR) from endosomes to the trans-Golgi network. Interacts with membranes containing phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2).
序列相似性Belongs to the sorting nexin family. Contains 1 BAR domain. Contains 1 PX (phox homology) domain.
细胞定位Endosome membrane. Golgi apparatus > trans-Golgi network membrane. Early endosome membrane. Enriched on tubular elements of the early endosome membrane. Binds preferentially to highly curved membranes enriched in phosphatidylinositol 3-phosphate (PtdIns(3P)) or phosphatidylinositol 3,5-bisphosphate (PtdIn.
99286 (3.8µg/ml) staining of paraffin embedded Human Uterus tissue following Steamed antigen retrieval with citrate buffer pH 6 and AP-staining shows vesicular staining in the cytoplasm of endometrial epithelium.
Western blot - SNX1 antibody (ab99286)
Anti-SNX1 antibody (ab99286) at 1 µg/ml + HeLa cell lysate in RIPA buffer at 35 µg Developed using the ECL technique
Predicted band size : 59 kDa Primary incubation was 1 hour.
Anti-SNX1 antibody (ab99286)参考文献
has not yet been referenced specifically in any publications.